Many launches can get lost in the fog of NHS governance. Who actually holds the decision-making power? The next video explores:

• Formal vs informal influencers
• Role of:
  • ICS leadership
  • Provider boards
  • Clinical leadership
  • Digital / transformation teams
• Governance timelines and approval bottlenecks
• What evidence decision-makers will expect to see

Even the best ideas fail if there’s no capacity. Life Science Companies need appropriate NHS staffing for their launch product. Here Julian looks into:

• Workforce implications (new skills, training, backfill)
• Impact on already stretched teams
• Clinical engagement and ownership
• Change fatigue and morale
• Whether delivery depends on scarce roles (digital, analysts, specialist clinicians)

If you can’t measure it, it won’t survive. Can you prove your launch product works for the NHS?

Here Julian Snape looks into what success looks like - in NHS terms:

• Metrics that matter locally vs nationally
• Data availability and quality
• Reporting burden
• How quickly benefits will be visible
• Alignment with existing performance frameworks

Launch is the beginning, not the end, and companies need to consider how the brand will be phased and scaled.

In our seventh video HSJ Information explores:

• Dependencies (IT, estates, suppliers, approvals)
• Integration with existing systems and pathways
• Realistic timelines
• What tends to go wrong and how to mitigate it
• Learning from similar implementations elsewhere

How the launch is framed can be as important as what it is. In our eighth video Julian Snape discusses how the change should be positioned to different audiences, looking at:

• Clinical, managerial, political narratives
• Patient and public implications
• Media and reputational risk
• Internal comms vs external messaging
• Anticipating resistance and objections

Considering your brand's impact on equity and access, and using system-wide thinking, is increasingly non-optional. In HSJ Information's penultimate video in our Countdown to Launch series, Julian Snape discusses:

• Impact on health inequalities
• Risk of widening variation
• Digital exclusion or access issues
• Unintended knock-on effects elsewhere in the system
• Regulatory or ethical considerations

Measurability and metrics are as important to the NHS as to Industry for a good launch. In our final video, Julian gives his insight on:

• What good looks like at 6, 12, 24 months
• How learning feeds into wider system change
• How organisations can sense-check progress
• When to pivot, pause, or stop

Before launching anything into the NHS, it’s essential to understand the environment you’re stepping into.

In the first instalment, Julian explores:

 • Current national priorities

 • Where your launch fits within the NHS operating model

 • The impact of recent policy changes, guidance, or funding announcements

 • Political timing risk

 • Alignment with ICS maturity and variation

Not all “the NHS” wants the same thing at the same time. Industry needs a clear articulation of the problem you’re solving, and in idea of where need is most acute, and where it isn’t.

In our second video Julian explores:

• Variation across Regions / ICSs/Provider types 
• System maturity
• Evidence base: what data supports the case for change?
• What has already been tried — and why it stalled or failed

A launch lives or dies on funding reality. Here HSJ Information look at who pays, why they pay - and why they might not.

• Who pays — and from which budget?
• Capital vs revenue implications
• Short-term cost pressures vs long-term savings
• Incentive or perverse incentives
• Impact of financial control regimes and recovery plans
• Whether the business case stacks up under current scrutiny levels